Oscar Salvatierra founded Stanford’s pediatric kidney transplant program, helped write the national legislation that regulates organ transplants, and conducted research in kidney transplantation.

On Dec. 14, 2014, after many months of not getting expected results, biochemist Jim Spudich got into bed, read a chunk of a novel, fell asleep and had a dream that would change the focus of his entire field in thinking about what causes a common and often lethal heart defect.

Edward Rubenstein was an internist, an educator and an investigator of varied research topics, including synchrotron medical imaging.

On March 15, Stanford medical students nervously awaited the moment they could find out where they had matched for their residencies.

Stanford researchers have found a way to predict who will suffer heart problems from a common breast-cancer drug, as well as identified an FDA-approved medication that could mitigate those side effects.

The role of democracy in public health leads to dramatic decreases in deaths from noncommunicable diseases, HIV, cardiovascular disease and transportation injuries, according to a new study by researchers at Stanford and several other institutions.

Researchers from throughout Stanford Medicine are planning to study thousands of metabolites in babies, children and pregnant women to understand the origins of disease.

Stanford researchers have found that transient changes in the numbers and activation levels of a handful of circulating immune cell types can predict the likelihood of dementia one year after a stroke.

Stanford researchers, physicians and medical educators have built partnerships around the globe to try to solve some of the most vexing health problems.

Even a relatively simple heart defect makes a patient much more likely to develop cardiovascular disease as an adult, Stanford researchers say.